Log in to search using one of your social media accounts:


Cytokinetics ALS Drug Fails

Cytokinetics, a biotechnology company, had hoped that by focusing on improving the function of muscle, not nerves, it could have an impact on lung function in patients with amyotrophic lateral sclerosis, popularly known as Lou Gehrig's disease, a nerve-destroying disorder. It didn't work.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news

Related Links:

More News: ALS | Biotechnology | Pharmaceuticals